John O'Brien, the senior adviser to HHS Secretary Alex Azar on drug-pricing reform, will step down from his position Aug. 22.

Canadians, furious about the Trump administration's plan to allow the importation of their prescription drugs, are discussing several ways to stop the proposal, according to STAT.

Most insurers and pharmacy benefit managers haven't placed the cheaper version of insulin manufactured by Eli Lilly on their lists of covered drugs, according to the Financial Times.

Rite Aid, a drugstore chain with 2,466 stores across the country, has named Heyward Donigan CEO, effective immediately.

Drugmakers are striking deals with hospital systems to mine the genetic profiles of patients, igniting concerns about the control of this genetic data, according to The Wall Street Journal.

Daiichi Sankyo, which has a U.S. headquarters in Basking Ridge, N.J., will lay off 69 members of its opioid pain medication sales force by October, according to ROI-NJ.com.

Ten hospitals and health systems posted job listings seeking pharmacy leaders in the last week.

The Drug Enforcement Administration suspended Oak Hill (W. Va.) Hometown Pharmacy's certificate of registration after an investigation found it posed an "imminent danger to the public health and safety" of its citizens, according to local news station WSAZ.

Bayer is offering to pay up to $8 billion to settle thousands of lawsuits claiming its weedkiller causes cancer, according to Bloomberg.

A shortage of a drug used to treat immune disorders has forced U.S. hospitals and infusion clinics to ration it or suspend treatment for many patients who use it, according to The Wall Street Journal.